$IDYA 3 SEC Filings

Filed On	Filing
05 Jun 2026	Form 3: Ross Theodora, Chief Development Officer
27 Jun 2025	Form 3: Bleharski Joshua, Chief Financial Officer
20 Dec 2024	Form 3: Dorman Stuart, Chief Commercial Officer
27 Sep 2024	Form 3: Snyder Douglas B., SVP, General Counsel No securities owned
03 Jul 2023	Form 3: Ruiz Briseno Andres, See Remarks Holds 34,531 shares of Common Stock
14 Dec 2022	Form 3: Beaupre Darrin, SVP, Chief Medical Officer
06 Apr 2022	Form 3: Mackey Catherine J, Director No securities owned
27 Oct 2021	Form 3: White Michael Anthony, SVP, Chief Scientific Officer No securities owned
17 Feb 2021	Form 3: Kelley Susan L., Director No securities owned
30 Jun 2020	Form 3: Hampton Malcolm Garret, Director No securities owned
22 Jun 2020	Form 3: Bvf Partners L P/IL, 10% owner and 9 others Holds 1,602,932 shares of Common Stock, $0.0001 par value
19 Dec 2019	Form 3: Yarno Wendy L, Director No securities owned
11 Oct 2019	Form 3: Throne Jason, VP, General Counsel No securities owned
23 May 2019	Form 3: 5AM Ventures IV, L.p., 10% owner and 4 others Holds 304,200 shares of Common Stock
22 May 2019	Form 3: Diekman John D, Director Holds 304,200 shares of Common Stock
22 May 2019	Form 3: Shannon Timothy M, Director
22 May 2019	Form 3: Alexandria Venture Investments, Llc, 10% owner
22 May 2019	Form 3: Canaan X L.p., 10% owner and 1 other
22 May 2019	Form 3: Lackner Mark, SVP, Head of Biology
22 May 2019	Form 3: Stone Paul A., SVP, General Counsel

Comments